Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · GUJTHEM

GUJ.THEMIS.

HealthcarePharmaceuticals & Biotechnology₹4243 cr market cap
₹352.70 ▼ -1.81% today As of 20 Nov 2026
52-week low ₹226.9052-week high ₹453.25

-20.8% from the 52-week high · +58.3% above the low

Gujarat Themis Biosyn Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Mumbai, Maharashtra and currently employs 109 full-time employees. Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The firm is focused on the business of manufacturing and sale of finished active pharmaceutical ingredients (API) products by fermentation process. The firm operates through manufacturing of the bulk drugs segment. Its product portfolio comprises Rifamycin-O and Rifamycin-S. The firm is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin (an Antibiotic used for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.) and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin (this is an Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy). Its research and development division focuses on developing fermentation cultures.

The short version. Promoter holding was 59.33% in Sep 2026, down 11.53 points over 8 quarters.

1 · The price

How has the stock traded?

GUJ.THEMIS. trades 20.8% below its 52-week high and 58.3% above its 52-week low.

Change over period: —

1M+0.2%
3M-2.7%
6M+0.6%
1Y-17.9%

2 · The business

Is it growing?

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026
Revenue5044
Net profit-1411
Net margin %-27.725.3
EPS (₹)-1.061.02

4 · The owners

Who holds it, and are they adding?

Promoter holding59.33%

Down 11.53 pts over 8 quarters.

Foreign institutions3.8%

Up 2.38 pts over 8 quarters.

Domestic institutions12.65%

Up 11.48 pts over 8 quarters.

Mutual fund schemes13

+1 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter70.8670.8670.8670.8670.8670.8670.8659.33-11.53
FII1.421.912.512.951.961.81.773.8+2.38
DII1.171.171.171.171.171.181.1812.65+11.48
Public26.5426.0525.4525.0126.026.1626.1924.22-2.32

Mutual fund holdings · Oct 2026

13 schemes hold this stock

12 the month before.

  • quant Equity Savings Fund7.36% of NAV
  • quant Manufacturing Fund5.45% of NAV
  • SAMCO MULTI ASSET ALLOCATION FUND3.94% of NAV
  • SAMCO ACTIVE MOMENTUM FUND1.27% of NAV
  • Bank of India Value Fund1.22% of NAV
  • Bank Of India Manufacturing and Infrastructure Fund1.02% of NAV
  • Bank Of India SMALL CAP FUND0.96% of NAV
  • Bank Of India Flexi Cap Fund0.84% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for GUJ.THEMIS. are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about GUJ.THEMIS.

What is the GUJ.THEMIS. share price?

GUJ.THEMIS. (GUJTHEM) last closed at ₹352.70, down 1.81% on the day. Its 52-week range is ₹226.90 to ₹453.25.

What is the market cap of GUJ.THEMIS.?

GUJ.THEMIS. has a market capitalisation of about ₹4,243 crore.

How are GUJ.THEMIS.'s latest results?

Promoter holding was 59.33% in Sep 2026, down 11.53 points over 8 quarters.

Who owns GUJ.THEMIS.?

As of Sep 2026, shareholding was: Promoter 59.33%, FII 3.8%, DII 12.65%, Public 24.22%.

How many mutual funds hold GUJ.THEMIS.?

13 mutual fund schemes held GUJ.THEMIS. in October 2026. That compares with 12 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 04 Sep 2025 · Final Dividend - Rs. 0.67
  • 09 Aug 2024 · Bonus issue 1:2
  • 15 Jul 2024 · Final Dividend - Rs. 0.25
  • 22 Feb 2024 · Interim Dividend - Rs. 0.75
  • 10 Oct 2023 · Stock Split From Rs.5/- to Rs.1/-
  • 01 Sep 2023 · Final Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.